Filing Details

Accession Number:
0001127602-12-020585
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-21 16:03:52
Reporting Period:
2012-06-19
Filing Date:
2012-06-21
Accepted Time:
2012-06-21 16:03:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1542768 E Maria Cantor C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Svp, Corporate Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-06-19 7,500 $3.08 41,602 No 4 M Direct
Common Stock Disposition 2012-06-19 7,500 $18.00 34,102 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-06-19 7,500 $0.00 7,500 $3.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,500 2018-09-11 No 4 M Direct
Footnotes
  1. Shares were acquired upon the exercise of outstanding stock options at $3.08 per share.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011.
  3. Options vest 25% per year on each September 11, of 2009, 2010, 2011 and 2012.